These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 23954895)

  • 1. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.
    Kunkel GT; Maceyka M; Milstien S; Spiegel S
    Nat Rev Drug Discov; 2013 Sep; 12(9):688-702. PubMed ID: 23954895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting sphingosine-1-phosphate signaling for cancer therapy.
    Xie Z; Liu H; Geng M
    Sci China Life Sci; 2017 Jun; 60(6):585-600. PubMed ID: 28623546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate and immune regulation: trafficking and beyond.
    Chi H
    Trends Pharmacol Sci; 2011 Jan; 32(1):16-24. PubMed ID: 21159389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
    Tsai HC; Han MH
    Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives on the role of sphingosine 1-phosphate in cancer.
    Pyne S; Pyne NJ
    Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The S1P-S1PR Axis in Neurological Disorders-Insights into Current and Future Therapeutic Perspectives.
    Lucaciu A; Brunkhorst R; Pfeilschifter JM; Pfeilschifter W; Subburayalu J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32580348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the role of sphingosine 1-phosphate in cancer.
    Pyne NJ; Pyne S
    FEBS Lett; 2020 Nov; 594(22):3583-3601. PubMed ID: 32969034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy?
    Dai L; Xia P; Di W
    Cancer Invest; 2014 Mar; 32(3):71-80. PubMed ID: 24499107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate signalling in cancer.
    Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
    Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase 1 as an anticancer therapeutic target.
    Gao Y; Gao F; Chen K; Tian ML; Zhao DL
    Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate transporters as targets for cancer therapy.
    Nagahashi M; Takabe K; Terracina KP; Soma D; Hirose Y; Kobayashi T; Matsuda Y; Wakai T
    Biomed Res Int; 2014; 2014():651727. PubMed ID: 25133174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
    Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications.
    Vito CD; Hadi LA; Navone SE; Marfia G; Campanella R; Mancuso ME; Riboni L
    Platelets; 2016 Jul; 27(5):393-401. PubMed ID: 26950429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
    Schwalm S; Pfeilschifter J; Huwiler A
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate (S1P) induces potent anti-inflammatory effects in vitro and in vivo by S1P receptor 4-mediated suppression of 5-lipoxygenase activity.
    Fettel J; Kühn B; Guillen NA; Sürün D; Peters M; Bauer R; Angioni C; Geisslinger G; Schnütgen F; Meyer Zu Heringdorf D; Werz O; Meybohm P; Zacharowski K; Steinhilber D; Roos J; Maier TJ
    FASEB J; 2019 Feb; 33(2):1711-1726. PubMed ID: 30188757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.
    Orr Gandy KA; Obeid LM
    Biochim Biophys Acta; 2013 Jan; 1831(1):157-66. PubMed ID: 22801037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.
    Takabe K; Paugh SW; Milstien S; Spiegel S
    Pharmacol Rev; 2008 Jun; 60(2):181-95. PubMed ID: 18552276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer.
    Nguyen AV; Wu YY; Lin EY
    World J Gastroenterol; 2014 Aug; 20(30):10279-87. PubMed ID: 25132744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.